Search

​On May 18, 2023, the Supreme Court unanimously affirmed the Federal Circuit's decision, Amgen Inc. v. Sanofi, 987 F.3d 1080 (Fed. Cir. 2021), that the claims of two of Amgen's patents were invalid for lack enablement. The involved patents, US 8,829,165 and US 8,859,741, are directed to monoclonal...

Education Session: The British are Coming! (& the Germans, New Yorkers, etc.) Working Across Markets A panel of CRE experts discuss strategies and advice on facilitating deals across state and international borders. From tax laws to cultural dos and don'ts, get advice on how to close deals...